News, Media & Events

Keeping the patient at the heart of our research

Keeping the patient at the heart of our research: My take-homes from speaking at the C3 Summit discussing inclusivity and diversity in...

MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)

SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC...

Continuing our legacy for more than 30 years with our free memory clinics

At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988. Whilst we now operate as a...

MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign

The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and...

MAC Opens US Office/Study Site

To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in the...

MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial

Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...

MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD

MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.

PRESS RELEASE: Initiator Pharma reports positive Phase IIa clinical data for IPED2015 in patients w

Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced...

Peter Dewland, Senior Director of Early Phase Research at MAC Clinical Research, Elected as Chair of

In recognition of 40 years devoted to early phase clinical research, Peter Dewland, BSc, MA, MBBS, FFPM, DCPSA, Senior Director of Early...

PRESS RELEASE: MAC Clinical Research expands its Global Site Network and access to patients in Aust

October 24, 2018 MANCHESTER, ENGLAND Across every clinical trial, Pharma and Biotech have a dire need to access patients in efficient...

Keeping the patient at the heart of our research

MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)

MAC Opens US Office/Study Site

MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD

MAC Achieves Cyber Essentials Certification

HOT OFF THE PRESS!! - JOBS - CAREERS WITH MAC

PRESS RELEASE: MAC Clinical Research expands its Global Site Network and access to patients in Aust

MAC GMP Pharmacy Manufacturing Service - Pharmacy MIA(IMP) Licenced Production Unit

Defying Dementia - Help the fight against dementia

Dr Mark Dale Receives Honorary Membership of the Faculty of Pharmaceutical Medicine

MAC CLINICAL RESEARCH